Independent Surveys Rank Top ASC Vendors for Client Satisfaction and User Experience Across 18 Key Performance Indicators DENVER, CO / ACCESS Newswire / April 29, 2025 / Black Book Research, the ...

The webcast will review the MVID and SBS-IF patient experience, the impact of crofelemer on disease progression and quality of life in MVID and SBS-IF, and possible expedited regulatory pathways for ...

Regarding Minimum Bid Price NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX) ("Protagenic Therapeutics" or the "Company"), a leader in biopharmaceutical ...

LOS GATOS, CA / ACCESS Newswire / April 29, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) ...

StudyAbivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis 29.04.2025 / 22:05 CET/CESTThe issuer is solely ...

LAS CRUCES, NEW MEXICO / ACCESS Newswire / April 29, 2025 / As newly appointed CMS Administrator Dr. Mehmet Oz renews focus ...

Takeda (TSE:4502/NYSE:TAK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the extension of the ...

LOS ANGELES, CA / ACCESS Newswire / April 29, 2025 / In the world of spine surgery, few conditions remain as misunderstood and underdiagnosed as Bertolotti Syndrome - a complex, often-overlooked cause ...

Rigorous humanized mouse model enhances credibility and translatability of results- Key preclinical data to support FDA Orphan Drug Application- In vitro success signals potential for exosome-based ...

LUND, SWEDEN / ACCESS Newswire / April 29, 2025 / The Annual General Meeting ("AGM") of BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV) resolved to re-elect the Board members Natalie ...

New offering empowers hospitals to enhance clinical excellence, streamline operations, and helps secure sustainable financial growth without disrupting existing clinician employment models. BRENTWOOD, ...

Biomanufacturers producing protein biologics including complex modalities, will have access to a full suite of custom cell ...